Selected research
Industry Growth & Trends
Global Immunity Nutraceutical Ingredient Industry Growth and Trends Forecast to 2032
Market perspective
The global Immunity Nutraceutical Ingredient market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Immunity Nutraceutical Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Immunity Nutraceutical Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Immunity Nutraceutical Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Immunity Nutraceutical Ingredient include Tate & Lyle PLC (U.K), Koninklijke DSM N.V. (Netherlands), Ingredion Incorporated (U.S), Arla Foods (Denmark) and Ajinomoto Co., Inc. (Japan), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Immunity Nutraceutical Ingredient market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Immunity Nutraceutical Ingredient market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Immunity Nutraceutical Ingredient market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Immunity Nutraceutical Ingredient.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Immunity Nutraceutical Ingredient market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Immunity Nutraceutical Ingredient Market by Company
Tate & Lyle PLC (U.K)
Koninklijke DSM N.V. (Netherlands)
Ingredion Incorporated (U.S)
Arla Foods (Denmark)
Ajinomoto Co., Inc. (Japan)
Immunity Nutraceutical Ingredient Segment by Type
Carotenoids
Minerals
Omega-3 fatty acids
Fibers & specialty carbohydrates
Phytochemical and plant extracts
Others
Immunity Nutraceutical Ingredient Segment by Application
Dietary supplements
Functional beverages
Functional food
Personal care
Animal nutrition
Immunity Nutraceutical Ingredient Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunity Nutraceutical Ingredient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunity Nutraceutical Ingredient and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunity Nutraceutical Ingredient.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunity Nutraceutical Ingredient manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Immunity Nutraceutical Ingredient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Carotenoids
- Minerals
- Omega-3 fatty acids
- Fibers & specialty carbohydrates
- Phytochemical and plant extracts
- Others
Applications
- Dietary supplements
- Functional beverages
- Functional food
- Personal care
- Animal nutrition
Companies covered
- Tate & Lyle PLC (U.K)
- Koninklijke DSM N.V. (Netherlands)
- Ingredion Incorporated (U.S)
- Arla Foods (Denmark)
- Ajinomoto Co., Inc. (Japan)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Immunity Nutraceutical Ingredient Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Immunity Nutraceutical Ingredient Sales Estimates and Forecasts (2021-2032)
- 1.3 Immunity Nutraceutical Ingredient Market by Type
- 1.3.1 Carotenoids
- 1.3.2 Minerals
- 1.3.3 Omega-3 fatty acids
- 1.3.4 Fibers & specialty carbohydrates
- 1.3.5 Phytochemical and plant extracts
- 1.3.6 Others
- 1.4 Global Immunity Nutraceutical Ingredient Market Size by Type
- 1.4.1 Global Immunity Nutraceutical Ingredient Market Size Overview by Type (2021-2032)
- 1.4.2 Global Immunity Nutraceutical Ingredient Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Immunity Nutraceutical Ingredient Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Immunity Nutraceutical Ingredient Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Immunity Nutraceutical Ingredient Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Immunity Nutraceutical Ingredient Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Immunity Nutraceutical Ingredient Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Immunity Nutraceutical Ingredient Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Immunity Nutraceutical Ingredient Industry Trends
- 2.2 Immunity Nutraceutical Ingredient Industry Drivers
- 2.3 Immunity Nutraceutical Ingredient Industry Opportunities and Challenges
- 2.4 Immunity Nutraceutical Ingredient Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Immunity Nutraceutical Ingredient Revenue (2021-2026)
- 3.2 Global Top Players by Immunity Nutraceutical Ingredient Sales (2021-2026)
- 3.3 Global Top Players by Immunity Nutraceutical Ingredient Price (2021-2026)
- 3.4 Global Immunity Nutraceutical Ingredient Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Immunity Nutraceutical Ingredient Major Company Production Sites & Headquarters
- 3.6 Global Immunity Nutraceutical Ingredient Company, Product Type & Application
- 3.7 Global Immunity Nutraceutical Ingredient Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Immunity Nutraceutical Ingredient Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Immunity Nutraceutical Ingredient Players Market Share by Revenue in 2025
- 3.8.3 2025 Immunity Nutraceutical Ingredient Tier 1, Tier 2, and Tier 3
4 Immunity Nutraceutical Ingredient Regional Status and Outlook
- 4.1 Global Immunity Nutraceutical Ingredient Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Immunity Nutraceutical Ingredient Historic Market Size by Region
- 4.2.1 Global Immunity Nutraceutical Ingredient Sales in Volume by Region (2021-2026)
- 4.2.2 Global Immunity Nutraceutical Ingredient Sales in Value by Region (2021-2026)
- 4.2.3 Global Immunity Nutraceutical Ingredient Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Immunity Nutraceutical Ingredient Forecasted Market Size by Region
- 4.3.1 Global Immunity Nutraceutical Ingredient Sales in Volume by Region (2027-2032)
- 4.3.2 Global Immunity Nutraceutical Ingredient Sales in Value by Region (2027-2032)
- 4.3.3 Global Immunity Nutraceutical Ingredient Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Immunity Nutraceutical Ingredient by Application
- 5.1 Immunity Nutraceutical Ingredient Market by Application
- 5.1.1 Dietary supplements
- 5.1.2 Functional beverages
- 5.1.3 Functional food
- 5.1.4 Personal care
- 5.1.5 Animal nutrition
- 5.2 Global Immunity Nutraceutical Ingredient Market Size by Application
- 5.2.1 Global Immunity Nutraceutical Ingredient Market Size Overview by Application (2021-2032)
- 5.2.2 Global Immunity Nutraceutical Ingredient Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Immunity Nutraceutical Ingredient Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Immunity Nutraceutical Ingredient Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Immunity Nutraceutical Ingredient Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Immunity Nutraceutical Ingredient Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Immunity Nutraceutical Ingredient Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Immunity Nutraceutical Ingredient Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Tate & Lyle PLC (U.K)
- 6.1.1 Tate & Lyle PLC (U.K) Company Information
- 6.1.2 Tate & Lyle PLC (U.K) Business Overview
- 6.1.3 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Product Portfolio
- 6.1.5 Tate & Lyle PLC (U.K) Recent Developments
- 6.2 Koninklijke DSM N.V. (Netherlands)
- 6.2.1 Koninklijke DSM N.V. (Netherlands) Company Information
- 6.2.2 Koninklijke DSM N.V. (Netherlands) Business Overview
- 6.2.3 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Product Portfolio
- 6.2.5 Koninklijke DSM N.V. (Netherlands) Recent Developments
- 6.3 Ingredion Incorporated (U.S)
- 6.3.1 Ingredion Incorporated (U.S) Company Information
- 6.3.2 Ingredion Incorporated (U.S) Business Overview
- 6.3.3 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Product Portfolio
- 6.3.5 Ingredion Incorporated (U.S) Recent Developments
- 6.4 Arla Foods (Denmark)
- 6.4.1 Arla Foods (Denmark) Company Information
- 6.4.2 Arla Foods (Denmark) Business Overview
- 6.4.3 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Product Portfolio
- 6.4.5 Arla Foods (Denmark) Recent Developments
- 6.5 Ajinomoto Co., Inc. (Japan)
- 6.5.1 Ajinomoto Co., Inc. (Japan) Company Information
- 6.5.2 Ajinomoto Co., Inc. (Japan) Business Overview
- 6.5.3 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Product Portfolio
- 6.5.5 Ajinomoto Co., Inc. (Japan) Recent Developments
7 North America by Country
- 7.1 North America Immunity Nutraceutical Ingredient Sales by Country
- 7.1.1 North America Immunity Nutraceutical Ingredient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Immunity Nutraceutical Ingredient Sales by Country (2021-2026)
- 7.1.3 North America Immunity Nutraceutical Ingredient Sales Forecast by Country (2027-2032)
- 7.2 North America Immunity Nutraceutical Ingredient Market Size by Country
- 7.2.1 North America Immunity Nutraceutical Ingredient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Immunity Nutraceutical Ingredient Market Size by Country (2021-2026)
- 7.2.3 North America Immunity Nutraceutical Ingredient Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Immunity Nutraceutical Ingredient Sales by Country
- 8.1.1 Europe Immunity Nutraceutical Ingredient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Immunity Nutraceutical Ingredient Sales by Country (2021-2026)
- 8.1.3 Europe Immunity Nutraceutical Ingredient Sales Forecast by Country (2027-2032)
- 8.2 Europe Immunity Nutraceutical Ingredient Market Size by Country
- 8.2.1 Europe Immunity Nutraceutical Ingredient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Immunity Nutraceutical Ingredient Market Size by Country (2021-2026)
- 8.2.3 Europe Immunity Nutraceutical Ingredient Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Immunity Nutraceutical Ingredient Sales by Country
- 9.1.1 Asia-Pacific Immunity Nutraceutical Ingredient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Immunity Nutraceutical Ingredient Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Immunity Nutraceutical Ingredient Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Immunity Nutraceutical Ingredient Market Size by Country
- 9.2.1 Asia-Pacific Immunity Nutraceutical Ingredient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Immunity Nutraceutical Ingredient Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Immunity Nutraceutical Ingredient Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Immunity Nutraceutical Ingredient Sales by Country
- 10.1.1 South America Immunity Nutraceutical Ingredient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Immunity Nutraceutical Ingredient Sales by Country (2021-2026)
- 10.1.3 South America Immunity Nutraceutical Ingredient Sales Forecast by Country (2027-2032)
- 10.2 South America Immunity Nutraceutical Ingredient Market Size by Country
- 10.2.1 South America Immunity Nutraceutical Ingredient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Immunity Nutraceutical Ingredient Market Size by Country (2021-2026)
- 10.2.3 South America Immunity Nutraceutical Ingredient Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Immunity Nutraceutical Ingredient Sales by Country
- 11.1.1 Middle East and Africa Immunity Nutraceutical Ingredient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Immunity Nutraceutical Ingredient Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Immunity Nutraceutical Ingredient Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Immunity Nutraceutical Ingredient Market Size by Country
- 11.2.1 Middle East and Africa Immunity Nutraceutical Ingredient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Immunity Nutraceutical Ingredient Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Immunity Nutraceutical Ingredient Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Immunity Nutraceutical Ingredient Value Chain Analysis
- 12.1.1 Immunity Nutraceutical Ingredient Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Immunity Nutraceutical Ingredient Production Mode & Process
- 12.2 Immunity Nutraceutical Ingredient Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Immunity Nutraceutical Ingredient Distributors
- 12.2.3 Immunity Nutraceutical Ingredient Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst